$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The use of fluorescently coupled α-bungarotoxin to study receptor localization and dynamics was pioneered in studies of the nicotinic acetylcholine receptor13-15, the toxin's endogenous target. Subsequently, incorporation of the minimal Bgt binding peptide (BBS) has been used to study trafficking of both excitatory and inhibitory ligand-gated ion channels and G protein coupled receptors2,10,16-21. This BBS-based technique provides advantages to other approaches used for trafficking studies such as surface biotinylation methods, antibody labeling of live cells with antibodies to extracellular epitopes, and fluorescence recovery after photobleaching (FRAP). During cell surface biotinylation free amines are covalently modified, with the potential to affect cellular activity. Antibody based studies have often been hampered by surface antigen clustering or capping, which can alter trafficking events. Due to the bleaching step for FRAP studies, an important concern is damaging the underlying cellular structure. An additional advantage is that BBS tagged constructs can also be used for biochemical methodologies with biotin-coupled bungarotoxin to asses receptor trafficking. This technique is readily applicable to cell lines and primary cells. For use in cells that express nicotinic acetylcholine (nAChR) receptors, the nAChR antagonist tubocurarine must be used throughout the protocol as indicated. Performing a simple surface Bgt labeling (equivalent to the T=0 time point for the endocytosis protocol) on untransfected cells in the absence of tubocurarine will provide evidence of endogenous nAChR.
An important consideration for using this technique is appropriate insertion of the BBS so that it is present at an extracellular location when the protein of interest is delivered to the plasma membrane. For example, the N-terminal domains of GABAAR subunits reside in the vesicular lumen during trafficking and become extracellular after receptor insertion in the plasma membrane, allowing specific labeling of cell surface receptors and assessment of their removal from the cell surface by endocytic events. We have previously shown that the addition of GFP, myc, or BBS epitopes to this domain of GABAAR subunits is functionally silent. Standard controls should be performed to ensure that the tagged protein is expressed at similar levels to an untagged construct, that it appropriately localized, and that it does not affect receptor function. This characterization of transfected constructs will also aid in troubleshooting overexpression concerns.